Everything by Chris.

Health and Healthcare

Vadadustat Makes the Case for Blockbuster Status After Japanese Chronic Kidney Disease Studies

Mar 12, 2019 Companies and Brands

Short Sellers Not So High on Marijuana Stocks

Mar 12, 2019 Energy

Short Sellers Run for Cover on Major Oil Stocks

Mar 12, 2019 Health and Healthcare

Major Biotechs See a Rising Tide in Short Interest

Mar 12, 2019 Health and Healthcare

Big Pharma Short Interest Backs Off, With One Huge Exception

Mar 12, 2019 Technology

Short Sellers Grow More Selective on Major Semiconductors

Mar 12, 2019 Health and Healthcare

Great News for Adolescents with Moderate to Severe Atopic Dermatitis

Mar 11, 2019 Investing

Monday’s Biggest Winners and Losers in the S&P 500

Mar 11, 2019 Health and Healthcare

Why Investors Are Hyped for Tonix Pharma’s PTSD Late-Stage Trial

Mar 11, 2019 Technology

Are Mellanox Shareholders Getting Enough in the Acquisition?

Mar 11, 2019 Health and Healthcare

What These 2 Neurodegenerative Studies Could Mean for the Future of Axovant

Mar 11, 2019 Technology

10 Reasons Merrill Lynch Is Now Bullish on Apple

Mar 11, 2019 Investing

Broadcom, Dollar General, Oracle and More Major Earnings Coming This Week

Mar 10, 2019 Investing

Friday’s Biggest Winners and Losers in the S&P 500

Mar 8, 2019 Technology

What Is Holding Marvell Technology Back in 2019

Mar 8, 2019 Health and Healthcare

Can Tonix Regain Its Former Glory With New Neurodegenerative Dysfunction Drug?

Mar 8, 2019 Retail

Can Costco Keep Up After Q1?

Mar 8, 2019 Investing

Thursday’s Biggest Winners and Losers in the S&P 500

Mar 7, 2019 Health and Healthcare

Bio-Path Shares on the Warpath

Mar 7, 2019 Media

Why One Analyst Sees Over 20% Upside at Netflix

Mar 7, 2019